Merit Medical Systems Inc/ US5898891040 /
21/05/2024 16:50:30 | Chg. -0.4200 | Volume | Bid16:50:30 | Ask16:50:30 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
82.6400USD | -0.51% | 8,249 Turnover: 232,205.6600 |
82.4700Bid Size: 400 | 82.7400Ask Size: 400 | 4.82 bill.USD | - | 50.55 |
Assets
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 331.4520 | 378.7850 | 382.7280 | 371.6580 | 382.9760 | ||||||
Intangible Assets | - | - | - | - | - | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 1,190.1780 | 1,302.7830 | 1,234.6890 | 1,166.0820 | 1,134.8820 | ||||||
Inventories | 197.5360 | 225.6980 | 198.0190 | 221.9220 | 265.9910 | ||||||
Accounts Receivable | 137.1740 | 155.3650 | 146.6410 | 152.3010 | 164.6770 | ||||||
Cash and Cash Equivalents | 67.3590 | 44.3200 | 56.9160 | 67.7500 | 58.4080 | ||||||
Current Assets | 429.8340 | 454.5380 | 429.7070 | 482.2120 | 529.0840 | ||||||
Total Assets | 1,620.0120 | 1,757.3210 | 1,664.3960 | 1,648.2940 | 1,663.9660 |
Liabilities
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 54.0240 | 54.6230 | 49.8370 | 55.6240 | 68.5040 | ||||||
Long-term debt | 373.1520 | 431.9840 | 343.7220 | 234.3970 | 186.7590 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 59.5000 | 48 | - | - | - | ||||||
Liabilities | 687.2370 | 807.3770 | 705.8210 | 608.4950 | 519.5690 | ||||||
Share Capital | 571.3830 | 587.0170 | 606.2240 | 641.5330 | 675.1740 | ||||||
Total Equity | 932.7750 | 949.9440 | 958.5750 | 1,039.7990 | 1,144.3970 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,620.0120 | 1,757.3210 | 1,664.3960 | 1,648.2940 | 1,663.9660 |
Income Statement
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 882.7530 | 994.8520 | 963.8750 | 1,074.7510 | 1,150.9810 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 58.6170 | 15.4340 | -1.5620 | 60.9160 | 87.5630 | ||||||
Interest Income | -9.1610 | -12.4130 | -9.9940 | -5.2610 | -6.3390 | ||||||
Income Before Taxes | 49.5190 | 2.1930 | -13.2310 | 53.9170 | 82.6290 | ||||||
Income Taxes | 7.5020 | -3.2580 | -3.3880 | 5.4630 | 8.1130 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 42.0170 | 5.4510 | -9.8430 | 48.4540 | 74.5160 |
Per Share
Cash Flow
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 86.5330 | 77.8130 | 165.2700 | 147.2310 | 114.2910 | ||||||
Cash Flow from Investing Activities | -378.8200 | -134.4810 | -58.6520 | -37.1610 | -57.3970 | ||||||
Cash Flow from Financing | 328.2800 | 33.5330 | -95.7060 | -98.4350 | -60.2600 | ||||||
Decrease / Increase in Cash | 35.0230 | -23.0390 | 12.5960 | 10.8340 | -7.1920 | ||||||
Employees | 5,783 | 6,355 | - | - | - |